Transcriptome Interferonopathy LMNA Autoimmune disease Interferon de type I Exercise Acetylcholine receptor antibodies CTCF Ferrites Follicular hyperplasia PBMC Etiology Autoimmunity Antimir-150 Thymus Heart failure Immunotherapy Puberty Immune regulation Myasthenia Gravis MG Clinical cell transplantation Age Cellules th17 Acides nucléiques endogènes Cardiomyopathy Disease susceptibility COVID-19 Experimental autoimmune myasthenia gravis EAMG Cell-cell communication Endogenous nucleic acids Th17 cells Quality of life Glucocorticoids Germinal centers Complete Freund's adjuvant Acetylcholine receptors Interféron de type I Conduction disease Il-23 Myoblasts Interferon-β Neuromuscular junction Chronicity Lamin A/C nuclei Thymoma CD31 Chemokines Experimental models Experimental mouse models Autoimmune diseases Chronic inflammation Immunity DICER Myasthenia gravis Interleukin 23 CXCL13-CXCR5 Gd T cells Early-onset myasthenia gravis Thymectomy Gender Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype Auto-immunité Long-term follow-up Immune response Inflammatory cytokines Chemokine Human myoblasts Cytokines Interferon Assay comparison Innate immunity Fragile X syndromes M3243AG Interferon IFN Centres germinatifs ectopiques MG patients Acetylcholine receptor Experimental autoimmune myasthenia gravis Germinal center Interleukine-23 BAFF Genetics Interferon type I Myasthenia Gravis Genetic associations Immunology and Microbiology Section Interferon type-I Adaptive immunity Inflammation Thymic epithelial cells Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration CCL21 Myasthénie grave AChR antibodies FMR1 Ectopic germinal centers Animal models Anticorps monoclonal COX2 B cells